Searchable abstracts of presentations at key conferences in endocrinology

ea0083to3 | Thyroid | EYES2022

Combined levothyroxine/liothyronine therapy improves quality of life in hypothyroid thyroidectomized patients

R. Corleto , G. Boselli , G. Margiotta , M. L. Monzani , A. Craparo , M. Locaso , S. Sperduti , N Roy , M. Simoni , V. Rochira , D. Santi , G. Brigante

Introduction: Despite normal thyroid stimulating hormone (TSH) serum levels, 10% of hypothyroid patients treated with LT4 complain of hypothyroidism symptoms, likely linked to decreased availability of free triiodothyronine (fT3). Thus, combined levothyroxine/liothyronine (LT4/lT3) therapy was suggested to ensure a more physiological balance in peripheral tissues.Aim: To evaluate the effectiveness of combined LT4/lT3 therapy in thyroidectomized subjects,...